C
Curve Biosciences
Unlocking the right data to help patients with chronic disease on their decades-long journey
About Curve Biosciences
Curve Biosciences is a biotechnology company focused on precision medicine for chronic disease care. The company develops diagnostic and therapeutic products that target the biological changes occurring in tissues, which contribute to chronic diseases. Curve Biosciences aims to unlock the potential of Chronic Epigenetics to bring precision to chronic disease care.
Read full description
Curve Biosciences is an early-stage company that is actively working on building its scientific team and advancing its research and development efforts. The company's business model likely revolves around the development and commercialization of its proprietary technologies and products. This could involve licensing agreements with larger pharmaceutical or biotech companies, as well as direct sales of its diagnostic and therapeutic solutions to healthcare providers and institutions.
At a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Dallas, United States
- Employees
- 27
- Open positions
- 2
- Dealroom signal
- 78.1/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Medical Research, Research and Development, Chronic Disease, Precision Medicine, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Oct 2025 | $40M | $160M | Incite · Civilization Ventures · First Spark Ventures · Mintaka | ↗ |
| EARLY VCOther financing | May 2024 | $18M | $71M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Curve Biosciences is 100 monthly website visits, down 94.1% over the last three months. Curve Biosciences's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A8 investors entered at this stage
Luma Group
Incite
Civilization Ventures
First Spark Ventures
Mintaka- MSMicah S
- TCTechas Capital
LifeX Ventures
Other known investors1 additional known investor
Stanford University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Curve Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Curve Biosciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.